Exagen inc. reports strong second quarter 2023 results

San diego, aug. 07, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended june 30, 2023.

XGN Ratings Summary

XGN Quant Ranking